ABSTRACT. In contrast to mvocardium from adult rabAbbreviations bits, myocardium from newborns is insensitive to the inotropic effects of selective inhibitors (e.g. amrinone, milrinone, and indolidan) of the cGMP-inhibited high-affinity cAMP phosphodiesterase (PDE) localized in the sarcoplasmic reticulum. This difference may be explained at least partially by our recent observation that this cAMP PDE activity is low in sarcoplasmic reticulum from newborns. Furthermore, because the predominant cytosolic high-affinity cAMP PDE activity in newborns is a cGMPinsensitive form, we postulated that selective inhibitors of this form of CAMP-specific PDE may increase cardiac contractility in newborns. Therefore, the inotropic effects PDE, phosphodiesterase SR, sarcoplasmic reticulum dT/dt, maximal rate of tension development NB, newborn IM, immature AD, adult IC50, concentration producing 50% inhibition RT, resting tension -dT/dt, maximal rate of relaxation of RO 20-1724 and S Q 65,442 (selective inhibitors of cGMP-insensitive, high-affinity cAMP PDE) were compared with trequinsin (a potent, less selective PDE inhibitor) in right ventricular papillary muscles isolated from newborn (NB; 24-48 h), immature (14-16 d), and adult New Zealand White rabbits. At a drug concentration of 100 pm, RO 20-1724 and S Q 65,442 depressed maximal rate of tension development to 67 f 4 and 70 f 2% of control, respectively, in NB papillary muscles. The NB response to RO 20-1724 differed significantly from the immature (127 f 2%) and adult (115 f 3%) groups ( p c 0.05), but the effects of S Q 65,442 were comparable among the three age groups. In contrast, trequinsin exerted a positive inotropic effect in the NB group (355 f 22% of control) that was substantially greater than the maximal response obtained in the immature (139 f 6% of control) or adult (131 2 5% of control) groups ( p < 0.01). These differences in inotropic responsiveness could not be explained by differences in sensitivity to drug-induced inhibition of cAMP or cGMP hydrolysis in cytosolic fractions from the three age groups. Thus, selective inhibitors of the predominant form of high-affinity cAMP PDE in NB myocardium do not exert a positive inotropic response in NB papillary muscles. The age-specific cardiotonic effects of trequinsin suggest that other PDE isozymes could contribute to the modulation of contractility during postnatal maturation. (Pediatr Res
of RO 20-1724 and S Q 65,442 (selective inhibitors of cGMP-insensitive, high-affinity cAMP PDE) were compared with trequinsin (a potent, less selective PDE inhibitor) in right ventricular papillary muscles isolated from newborn (NB; 24-48 h), immature (14-16 d) , and adult New Zealand White rabbits. At a drug concentration of 100 pm, RO 20-1724 and S Q 65,442 depressed maximal rate of tension development to 67 f 4 and 70 f 2% of control, respectively, in NB papillary muscles. The NB response to RO 20-1724 differed significantly from the immature (127 f 2%) and adult (115 f 3%) groups ( p c 0.05), but the effects of S Q 65,442 were comparable among the three age groups. In contrast, trequinsin exerted a positive inotropic effect in the NB group (355 f 22% of control) that was substantially greater than the maximal response obtained in the immature (139 f 6% of control) or adult (131 2 5% of control) groups ( p < 0.01). These differences in inotropic responsiveness could not be explained by differences in sensitivity to drug-induced inhibition of cAMP or cGMP hydrolysis in cytosolic fractions from the three age groups. Thus, selective inhibitors of the predominant form of high-affinity cAMP PDE in NB myocardium do not exert a positive inotropic response in NB papillary muscles. The age-specific cardiotonic effects of trequinsin suggest that other PDE isozymes could contribute to the modulation of contractility during postnatal maturation. (Pediatr Res 31: 300-304, 1992) Cyclic nucleotide PDE play a central role in the modulation of contractile function in mature myocardium. Physiologic or pharmacologic interventions that increase intracellular cAMP (such as P-adrenergic stimulation) result in activation of CAMPdependent protein kinase, phosphorylation of key regulatory proteins, and increased contractility (1) (2) (3) (4) (5) . Hydrolysis of cAMP is catalyzed by a family of cyclic nucleotide PDE. Thus, the distribution and activity of CAMP-specific PDE are important determinants of the inotropic state and drug responsiveness.
Cyclic nucleotide PDE can be classified according to their relative substrate affinities and effects of cGMP and Ca2+/calmodulin on hydrolytic activity (6) . High-affinity cAMP PDE activity exists in two major forms in mammalian myocardium: the class I11 cGMP-inhibited PDE that is also sensitive to inhibition by cardiotonic drugs such as milrinone and a cardiotonic drug-insensitive form that is not sensitive to inhibition by cGMP. This cGMP-insensitive form belongs to the class IV (CAMPspecific) PDE family. PDE activity in the SR is almost exclusively the cGMP-inhibited class I11 PDE (7) (8) (9) (10) (11) (12) . In contrast, the soluble or cytosolic fraction of rabbit myocardium contains both cGMPinhibited (class 111) and cGMP-insensitive (class IV) high-affinity cAMP PDE activities (7, 12) .
Evidence has accumulated to support the concept that the major site of action of cardiotonic PDE inhibitors such as milrinone, indolidan, and imazodan is the SR-associated cGMPinhibited class I11 PDE (7-1 3). Myocardium from NB animals is relatively insensitive to this class of agents (14) (15) (16) (17) , consistent with our observation of diminished cGMP-inhibited class I11 PDE activity in NB SR (12) . Unlike that in AD rabbits, highaffinity cAMP PDE activity in the cytosolic fraction from NB myocardium is predominantly the class IV, cGMP-insensitive, cardiotonic drug-insensitive form (12) . Therefore, we postulated that selective inhibitors of the predominant form of high-affinity cAMP PDE activity in NB myocardium (the cGMP-insensitive PDE INHIBITORS IN R ABBIT MYOCARDIUM 30 1 class IV form) would produce a positive inotropic effect in the NB heart. This hypothesis was tested by determining the inotropic responses to two different selective inhibitors of CAMP-specific class IV PDE (RO 20-1724 and SQ 65,442) (7, (18) (19) (20) (21) during postnatal maturation in the rabbit. Results were compared with those obtained using a potent, but more generalized PDE inhibitor (trequinsin) (21, 22) . To relate the inotropic responses to inhibition of PDE activity, cytosolic fractions from each age group were assayed for sensitivity to inhibition of cAMP and cGMP hydrolysis.
MATERIALS AND METHODS
Animals. All experiments were performed using New Zealand White rabbits of either sex from three age groups: NB, 24 to 48 h of age; IM, 14 to 16 d of age; and sexually mature AD, 6 to 8 mo of age. Timed-pregnant rabbits delivered in our animal care facility to allow precise aging of the litters. NB and IM rabbits were housed with their mothers. Hearts from lactating rabbits were not used for these experiments. All animals were deeply anesthetized with sodium pentobarbital (50-75 mg/kg) administered intraperitoneally (NB and IM) or i.v. (AD) before removal of the heart. Our laboratory follows the highest standards of humane care and adheres to NIH guidelines for proper animal care. These experimental protocols were reviewed and approved by the University of South Alabama Institutional Animal Care and Use Committee.
Contractile responses. Each heart was rapidly excised and placed in ice-cold normal saline. Right ventricular papillary muscles were removed immediately and prepared to contract isometrically in Krebs bicarbonate buffer (125 mM NaCl, 2.3 mM KCl, 2.5 mM CaC12, 25 mM NaHC03, 5.6 mM dextrose, 1.3 mM KH2P04 and 0.6 mM MgS04) at 30°C. A mixture of 95% oxygen and 5% carbon dioxide was continuously bubbled through the buffer (pH 7.35-7.4). Each muscle was stimulated to contract using a square-wave pulse of 3 ms duration at a frequency of 0.5 Hz. Muscles were gradually stretched to the optimum length for maximal tension development, then allowed to equilibrate for 20-30 min before drug exposure. Only muscles with a cross-sectional area 5 1 mm2 were included in the analyses. Cross-sectional area was calculated from the length and wet weight of each muscle at the completion of each experiment. The muscle length was measured from the calibrated micromanipulator used to adjust the height of the force transducer. Each muscle was removed from the clamp, the base and chordae were trimmed away, the muscle was blotted, and the wet weight was determined.
RT, developed tension, time to peak tension, dT/dt, time from peak tension to 90% relaxation, and -dT/dt were averaged for four consecutive contractions for any given conditions. Developed tension, dT/dt, -dT/dt, and RT were normalized to 1 mm2 cross-sectional area to facilitate comparisons among the different age groups.
Four to seven muscles were used for each drug in each group. Cumulative dose-response relationships (1 to 300 pM) were obtained using a single drug for each muscle. Stock solutions prepared in DMSO were diluted with Krebs bicarbonate buffer, resulting in a final DMSO concentration of less than 1 %. DMSO at this concentration had no significant effect on contractility in control studies in all age groups. Maximal drug effects occurred between 5 and 10 min (independent of age group) and were recorded approximately 10 min after the addition of each drug dose. Thus, cumulative dose-response studies required no longer than 90 min to complete.
Inhibition of PDE activities. Ventricular myocardium was trimmed of atria, great vessels, and gross epicardial fat. All procedures were performed at 4°C. Approximately 15-20 g of tissue were used for each adult preparation (two adult hearts were pooled for each different preparation), and 7-10 g were used for immature and newborn preparations (this required pooling of several littermates). The myocardium was minced and added to 10 volumes (1 g/10 mL) of buffer containing 4 mM EDTA, 20 mM NaCl, 10 mM benzamidine, 1 KIU/mL aprotinin, 2 pM leupeptin, 10 pM n-tosyl-1-lysine chloromethyl ketone, and 2 pM pepstatin-A. Samples were homogenized with a Brinkmann Polytron PT-20 (Brinkmann Instruments, Co., Westbury, NY) using three 30-s bursts at half-maximal setting. Homogenates of AD myocardium were filtered through gauze to remove fat, but this step was not required for the younger age groups. Homogenates were centrifuged for 20 min at 30 000 x g. For NB and IM preparations, the resultant supernatants were suspended in ethylene glycol (final concentration of ethylene glycol was 30%) and stored briefly at -20°C until analyzed. For adult preparations, the high-affinity cAMP activities in the supernatant were partially purified (peak 111) by anion exchange chromatography as previously described from our laboratory (8, 12) . Adult samples were suspended in 30% ethylene glycol and stored briefly at -20°C for subsequent analyses. These methods for obtaining cytosolic preparations result in recovery of approximately 85-90% of total homogenate high-affinity cyclic nucleotide PDE activity regardless of age group.
PDE assays were performed according to routine procedures in our laboratory (8, 12, 16, 23, 24) . Cytosolic fractions were assayed for hydrolysis of either 0.25 pM [3H]cAMP or 1 pM [3H] cGMP. Under these conditions with low substrate concentrations, the predominant PDE activities detected are those with high substrate affinity. The ICso determinations were performed using 10 different inhibitor concentrations ranging from 0.0 1 to 300 pM. Drugs were dissolved in 100% DMSO and then diluted appropriately. Control experiments using the same concentrations of DMSO, but without drug, demonstrated that the highest concentration of DMSO inhibited basal activity by approximately 20% in each age group. However, the effects of DMSO at concentrations near drug IC50 values were negligible (basal activity inhibited by less than 5%). of milrinone, a selective inhibitor of cGMP-inhibited class I11 Figure 1 illustrates the inotropic responses in papillary muscles PDE in the SR (14) (15) (16) (17) . We attributed this lack of response in each age group increasing Ro NB rabbits to a relative deficiency of SR-associated class 111 PDE 20-1724' In the NB group, loo pM Ro 20-1724 reduced dT/dt activity (12) . Based upon the that cytosolic highto 67 ' 4% of the pretreatment in affinity CAMP activity is predominantly the cAMP-specific class from IM and AD loo pM Ro 20-1724 IV form in the NB rabbit heart (12), we postulated that selective produced a slight increase in dT/dt to 127 ' 2 and 1 15 ' 3% of inhibitors of this activity would a positive inotropic effect control, respectively. As demonstrated in Table 2 , there were in NB myocardium. However, results from the present study age-related differences in the effects of RO 20-1724 on other indicate that two different selective inhibitors of cAMP-specific indices of contractile function. In the NB group, RO 20-1724 class IV PDE (SQ 65,442 and RO 20-1724) did not increase exerted a negative lusitro~ic effect (prolonged 90% relaxation myocardial contractility in papillary muscles isolated from NB time and reduced -dT/dt) and elevated RT. Opposite responses rabbits. This inotropic unresponsiveness occurred despite equivwere in the IM and AD groups with regard to these alent or even slightly greater sensitivity to inhibition of cAMP indices of contractile function.
hydrolysis. The increased sensitivity to inhibition of CAMP hy-SQ 65,442, another selective inhibitor of cAMP specific class drolysis by these drugs in the NB group is consistent with IV PDE, ~roduced a dose-dependent decrease in dT/dt in all age recognized age-related differences in the relative proportion of groups (~i~. 2). ~t 100 pM SQ 65,442, the reduction in dT/dt the two predominant forms of high-affinity cAMP PDE in the was not significantly different among the three different groups cytosol.
(65-75% of control). In addition to a negative inotropic effect, A, anticipated, these agents had little or no positive inotropic SQ 65,442 increased RT, prolonged the duration of contraction, effect in AD papillary muscles under these conditions (27) . and impaired relaxation in each age group (Table 2) .
Contractile responses and drug effects on PDE activities were The effects of trequinsin on dTldt in each age group are comparable in the IM and AD groups. These results along with illustrated in Figure 3 . The maximal positive inotropic response previous (231, suggest that by 14 d ofage, the cyclic in the NB group was significantly greater ( p < 0.01) than that nucleotide PDE system in the rabbit has undergone substantial ~b~r v e d in either the IM or AD group. The in development. Future studies of this system might benefit from contractility in the NB group was accompanied by a positive incorporating a late fetal and/or 7-&old age group. lusitropic effect (increased -dT/dt; Table 2 ) that was less pro-
The different pattern of responses to RO 20-1724 and SQ nounced in the other two age groups ( p < 0.05).
65,442 in mature myocardium suggests that subtle differences in TO facilitate compari~on~ of the maximal inotropic effect for pDE inhibition profiles may produce different contractile resuch age group and each drug, results for dT/dt at 100 PM drug sponses. In addition, these drugs may exert unrecognized effects concentration are summarized in Figure 4 . The inotropic effects 0, other subcellular mechanisms involved in the regulation of of the three PDE inhibitors differed among the age groups. BY 2 myocardial contractility. Conceivably, the negative inotropic wk of age (IM group) the AD Pattern of responses was fully effect of SQ 65,442 could be due to an additional drug action developed. Papillary muscles from NB animals exhibited a fall that is yet to be defined. in dT/dt in response to RO 20-1724 and SQ 65,442 . In contrast,
The lack of a positive inotropic response to high-affinity cAMP an NB-specific positive inotropic effect occurred after exposure PDE inhibitors in NB myocardium is not attributable to an to trequinsin.
inability to respond to increased intracellular levels of CAMP, Inhibition of PDE activities. The ability of the drugs to inhibit inasmuch as isoproterenol or forskolin produce a significant cytosolic cAMP hydrolysis was determined over a range of drug positive inotropic effect in NB rabbits (16) . The relatively greater concentrations to provide an index of the sensitivity to inhibition magnitude of the forskolin response observed in NB suggests that (IC~O values; Table 3 ). I C~O values were obtained using 0.25 pM the mechanisms for cAMP hydrolysis are incompletely developed cAMP as substrate to evaluate drug effects on high-affinity CAMP at birth in the rabbit. Trequinsin, a potent but much less selective PDE activity in the cytosolic mixture. As shown in Table 3 , all PDE inhibitor, was used to test whether or not generalized PDE three drugs are potent inhibitors of cytosolic cAMP hydrolysis, inhibition would improve contractility in the NB group. Unexwith NB preparations exhibiting slightly greater sensitivity. How-pectedly, trequinsin exerted an age-specific positive inotropic ever, within the NB group, ICso values for each drug were effect. Papillary muscles from NB animals exhibited a 3.5-fold comparable despite marked differences in the contractile re-increase in dT/dt. In contrast, there was only a very modest sponses to these agents. Because differences in sensitivity of effect of trequinsin in the IM and AD groups. cAMP hydrolysis did not adequately account for differences in At present, the specific PDE isozyme(s) responsible for the inotropic responsiveness and because cGMP may be an impor-response to trequinsin in NB rabbits is unclear. Recently, Muller tant modulator of cAMP PDE activities, the ability of trequinsin et al. (27) have shown that CAMP-specific class IV PDE may and SQ 65,442 to inhibit cGMP hydrolysis was determined in assume a role in regulating cardiac contractility in mature guinea response curves. PDE assays were performed using 0.25 pM cAMP as substrate. response elicited by trequinsin in the NB rabbit. Sensitivity to
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OQUIST inhibition of high-affinity cAMP PDE, as indexed by IC50 values (Table 3) , was comparable for each of the three drugs in the NB group, yet only trequinsin increased dT/dt. Furthermore, the previously reported lack of a positive inotropic response to selective inhibitors (e.g. milrinone) of the SR-associated cGMPinhibited class I11 cAMP PDE (14) (15) (16) (17) suggests that inhibition of this PDE isoform alone is not sufficient to account for the mechanism of action of trequinsin in the NB.
Trequinsin inhibited cGMP hydrolysis in the low micromolar range in all three age groups, consistent with the more generalized PDE inhibitory effects of this drug (in contrast to SQ 65,442 ICso values for cGMP hydrolysis). However, inhibition of cGMP hydrolysis alone does not appear to account for the age-related differences in inotropic responsiveness, because the trequinsin ICso values were quite comparable in the three age groups.
Taken in concert, the current results and the aforementioned previous findings provide evidence to support the concept that contractility and drug responsiveness in NB rabbit myocardium are modulated by PDE isoforms that differ from the PDE that predominant in the mature heart. It may be that a calciumcalmodulin-stimulated PDE (class I) or a cGMP-stimulated PDE (class 11) assumes a relatively greater role in regulating cAMP metabolism in the developing heart. Alternatively, the interaction of multiple PDE isoforms may be a more important determinant of the overall inotropic response, particularly in the developing heart. In addition, it is conceivable that trequinsin may exert unrecognized effects other than PDE inhibition that assume an important role in mediating the response in the NB heart. Drug effects in homogenates/cell-free systems may not always correlate with the pharmacodynamic response in intact tissues. For example, the ability of cardiotonic drugs to inhibit the SRassociated, cGMP-inhibited, high-affinity cAMP PDE correlates well with contractile responses in AD rabbit myocardium. In contrast, inhibition of cAMP hydrolysis by various drugs in rat brain homogenates does not correlate with the ability of these drugs to inhibit cAMP turnover in intact brain tissue slices (19) . Based upon our current results, we speculate that trequinsin would increase cAMP levels and activate CAMP-dependent protein kinase in NB myocardium but not in preparations from mature rabbits. Additional studies using inhibitors of class I and class I1 PDE could be tested to probe the role of these other PDE activities in regulating contractile function in the developing heart. In summary, we have shown that selective inhibitors of CAMPspecific class IV PDE do not increase contractility in NB rabbit myocardium. The age-specific positive inotropic effect of trequinsin suggests that the regulation of contractile function during perinatal maturation involves PDE isoforms that differ from those exerting a major influence in the mature heart. Furthermore, it may be possible to exploit these age-dependent differences by formulating inotropic agents (such as trequinsin) that exhibit selective therapeutic efficacy in the developing heart.
